Haemonetics Corp <HAE.N>: Citigroup Raises to Buy From Neutral; Raises Target Price to $123 From $92
HAE•Related News
CMG signs five-year software licensing, support agreement with Petrobras
PBR•
Factbox-Major brokerages see one more Fed rate hike in 2026 after policy meeting
SPY•
ReposiTrak begins Touchless Retail rollout after signing first supplier contracts
TRAK•
Core Scientific Inc. <CORZ.O>: Wells Fargo initiates coverage with overweight rating and target price $28
CORZ•
CVS Health's Aetna to streamline cancer treatment approvals
CVS•